Lack of effect of smoking on the metabolism and pharmacokinetics of quinidine in patients.
Open Access
- 1 March 1987
- journal article
- research article
- Published by Wiley in British Journal of Clinical Pharmacology
- Vol. 23 (3) , 351-354
- https://doi.org/10.1111/j.1365-2125.1987.tb03057.x
Abstract
The urinary metabolite profile of quinidine and the oral clearance of this drug were studied under steady state conditions in five smoking and nine non-smoking patients. No significant differences were observed in the urinary recovery of unchanged quinidine, 3S-3-hydroxyquinidine, 2′-oxoquinidinone or quinidine-N-oxide between smokers and non-smokers. In addition, the plasma clearance of quinidine was not affected by the smoking status of subjects. These results suggest that cigarette smoke does not induce any of the main pathways for quinidine metabolism in a typical patient population and that the consideration of smoking status is of little utility in aiding in the selection of initial dosage regimens for this drug.This publication has 10 references indexed in Scilit:
- Impaired enzyme induction by rifampicin in the elderly [letter]British Journal of Clinical Pharmacology, 1984
- Quinidine-Rifampin InteractionNew England Journal of Medicine, 1981
- Relation of ventricular premature beat suppression to serum quinidine concentration determined by a new and specificassayAmerican Heart Journal, 1980
- Clinical Pharmacokinetics of QuinidineClinical Pharmacokinetics, 1980
- Quinidine therapy in hospitalized patients with ventricular arrhythmiasAmerican Heart Journal, 1979
- Role of tobacco smoking in pharmacokineticsJournal of Pharmacokinetics and Biopharmaceutics, 1978
- SPECIFIC DETERMINATION OF QUINIDINE AND (3S)-3-HYDROXYQUINIDINE IN HUMAN-SERUM BY HIGH-PRESSURE LIQUID-CHROMATOGRAPHY1977
- Interaction of Quinidine with Anticonvulsant DrugsNew England Journal of Medicine, 1976
- Disposition kinetics of quinidineClinical Pharmacology & Therapeutics, 1976